Related Experiment Video
Updated: Jul 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Current concepts in the management of intracranial atherosclerotic disease
Robert D Ecker1, Elad I Levy, Eric Sauvageau
1Department of Neurosurgery,School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 14209, USA.
Insights
Symptomatic intracranial atherosclerotic disease poses a significant stroke risk. Advances in endovascular treatments offer new hope for managing this condition.
Area of Science:
- Neurology
- Vascular Neurology
- Interventional Neurology
Background:
- Medically refractory symptomatic intracranial atherosclerotic disease (ICAD) carries a poor prognosis.
- The Warfarin-Aspirin Symptomatic Intracranial Disease study indicated a 13-14% risk of ipsilateral stroke at 1.8 years for patients with symptomatic ICAD.
Purpose of the Study:
- To discuss recent clinical developments and concepts in the diagnosis and endovascular treatment of ICAD.
- To highlight advancements in angioplasty, stenting, neuroimaging, and antithrombotic regimens for ICAD.
Main Methods:
- Review of recent clinical developments and concepts.
- Discussion of synergistic advances in neuroimaging and endovascular techniques.
- Analysis of periprocedural and postprocedural antithrombotic strategies.
Main Results:
- Intracranial angioplasty and stenting, coupled with advanced neuroimaging and antithrombotic protocols, are evolving treatment paradigms.
- New models for diagnosis and successful endovascular management of ICAD are emerging.
Conclusions:
- Significant progress is being made in the endovascular treatment of intracranial stenosis.
- Improved diagnostic and therapeutic strategies are enhancing outcomes for patients with ICAD.
Abstract:
Medically refractory, symptomatic intracranial atherosclerotic disease has a poor prognosis. Based on the results of the Warfarin-Aspirin Symptomatic Intracranial Disease study, the risk of ipsilateral stroke at 1.8 years is between 13 and 14% in patients with symptomatic intracranial atherosclerosis. Synergistic advances in intracranial angioplasty and stenting, modern neuroimaging techniques, and periprocedural and postprocedural antithrombotic regimens are creating new models for the diagnosis and successful endovascular treatment of intracranial stenosis. In this article, the most recent clinical developments and concepts for the diagnosis and endovascular treatment of intracranial atherosclerotic disease are discussed.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Ischemic Stroke l: Introduction
